tiprankstipranks
Trending News
More News >
Icon Plc (ICLR)
:ICLR
US Market
Advertisement

Icon (ICLR) Earnings Dates, Call Summary & Reports

Compare
509 Followers

Earnings Data

Report Date
Oct 22, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
3.33
Last Year’s EPS
3.35
Same Quarter Last Year
Moderate Buy
Based on 14 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 23, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted strong gross business awards, improved cost management, and operational advancements, with significant share repurchases indicating financial strength. However, elevated cancellations and decreased year-on-year revenue posed challenges. The sentiment is balanced with promising growth but also notable obstacles.
Company Guidance
During ICON Plc's Q2 2025 earnings call, the company provided guidance reflecting an expected increase in full-year revenue, adjusting the range to $7.85 billion to $8.15 billion, with a midpoint of $8 billion. This adjustment comes despite an ongoing competitive environment and elevated cancellations, including a significant cancellation of a large next-generation COVID vaccine trial. The company anticipates maintaining its adjusted earnings per share guidance at $13.50, attributing the revenue increase primarily to higher pass-through revenues, which contributed to a 2.017 billion revenue in Q2, despite a year-on-year decrease of 4.8%. ICON highlighted a stable burn rate of 8.2% and an improved adjusted EBITDA margin of 19.6%. Additionally, ICON reported adjusted net income of $259.5 million, translating to adjusted earnings per share of $3.26, marking a sequential increase of 2.2%. The company continues to focus on several growth areas, including biotech partnerships and therapeutic areas like obesity, supported by its strategic cost management and operational efficiencies.
Increased Gross Business Awards
Gross business awards increased 11% on a sequential basis over quarter 1, with notable wins from several biotech customers and large pharma partnerships.
Revenue Performance Exceeds Expectations
Revenue in quarter 2 was $2.017 billion, representing a year-on-year decrease of 4.8%, but up approximately 1% sequentially on quarter 1 2025, with higher pass-through revenue assisting performance.
Improvement in Gross Margin and Cost Management
Gross margin improved over quarter 1 to 28.3%, and SG&A costs reduced by $9 million year-over-year, demonstrating efficient global operations.
Positive Developments in Key Operational Areas
Customer and site satisfaction scores improved due to accelerated site activation, patient recruitment, and trial completion. Investments in obesity and related metabolic diseases are progressing well.
Significant Share Repurchases
In quarter 2, $250 million in shares were repurchased, and a new share repurchase authorization for up to $1 billion was approved.

Icon (ICLR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ICLR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 22, 2025
2025 (Q3)
3.33 / -
3.35
Jul 23, 2025
2025 (Q2)
3.19 / 3.26
3.75-13.07% (-0.49)
Apr 30, 2025
2025 (Q1)
3.10 / 3.19
3.47-8.07% (-0.28)
Feb 19, 2025
2024 (Q4)
3.43 / 3.43
3.46-0.87% (-0.03)
Oct 23, 2024
2024 (Q3)
3.85 / 3.35
3.31.52% (+0.05)
Jul 24, 2024
2024 (Q2)
3.68 / 3.75
3.1120.58% (+0.64)
Apr 24, 2024
2024 (Q1)
3.41 / 3.47
2.919.66% (+0.57)
Feb 21, 2024
2023 (Q4)
3.46 / 3.46
3.1310.54% (+0.33)
Oct 25, 2023
2023 (Q3)
3.27 / 3.30
310.00% (+0.30)
Jul 26, 2023
2023 (Q2)
3.08 / 3.11
2.868.74% (+0.25)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ICLR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 23, 2025
$167.89$195.01+16.15%
Apr 30, 2025
$151.44$145.21-4.11%
Feb 19, 2025
$191.32$201.84+5.50%
Oct 23, 2024
$280.76$221.73-21.03%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Icon Plc (ICLR) report earnings?
Icon Plc (ICLR) is schdueled to report earning on Oct 22, 2025, After Close (Confirmed).
    What is Icon Plc (ICLR) earnings time?
    Icon Plc (ICLR) earnings time is at Oct 22, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ICLR EPS forecast?
          ICLR EPS forecast for the fiscal quarter 2025 (Q3) is 3.33.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis